3 M c.681T>G (Y156X) Unilateral Positive (CNS) Positive
PatientID: 3
KindredID: 3
Case: M, Age Unknown, Ethnicity Unknown
DiseaseAssertion: VHL
FamilyInfo: N/A
CasePresentingHPOs: HP:0000107; HP:0005584; HP:0010797; HP:0001737 (Renal cyst, Renal cell carcinoma, Hemangioblastoma, Pancreatic cysts)
CaseHPOFreeText: Unilateral RCC and renal cysts, CNS hemangioblastoma, positive for pancreatic cysts.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
PreviouslyPublished: N/A
SupplementalData: Table 1
Variant: p.Y156* (c.468T>G)
LegacyVariant: c.681T>G (Y156X)
CaseProblemVariantFreeText: N/A
ClinVarID: N/A
CAID: CA351756053, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.468T%3EG
gnomAD: N/A
VariantEvidence: Variant is declared as “c.681T>G (Y156X)” by the authors, this was treated as a legacy variant and mapped to c.468T>G, Y156*.This study found coexpression of Epo and EpoR in 11 RCCs and in 10 benign renal cysts in a spectrum of VHL renal disease suggesting that Epo/EpoR coexpression is present in both benign and malignant stages of renal neoplasia. Six benign cysts stained for Epo but not EpoR. The researchers detected loss of heterozygosity of a wild-type VHL allele in different RCCs with microsatellite markers, D3S1110 and D3S2452, flanking the VHL gene
MutationType: stop_gained; missense_variant;transversion
CivicName: Y156* (c.468T>G)
MultipleGeneVariants: N/A